COResearch provides centralized, Part 11 compliant ECG and Echo core laboratory services, seamlessly interlaced with a full suite of global clinical research services offered through Duke Medical Strategies to support all aspects of clinical trials. With its academic origins, full-service capabilities, cutting edge technology, and regulatory experience, no competitor is able to offer the same breadth of strategic and operational services in a single package.
COResearch is poised to facilitate new drug approval by optimizing cardiac safety and efficacy assessments of new molecular entities. Customized applications of cutting-edge digital monitoring technologies, combined with extensive research experience and the clinical expertise of the COResearch physician leadership, bring a unique advantage to the pharmaceutical, biotechnology, and medical device industries.
Formerly known as the Duke ECG Core Lab, this business unit of Duke Medical Strategies, Inc. provides digital core laboratory measures of cardiac safety and efficacy for new molecular entities and devices in Phase I through Phase IV clinical trials, with a specific focus on Thorough QT Studies.
COResearch capabilities encompass a full-range of cardiac safety and efficacy core laboratory services, including:
Logistic and Technical Support
Digital QT and Intervals Measurement
12-Lead Continuous and Resting ECG
Holter Arrhythmia Monitoring
High-Fidelity Single System Combined Arrhythmia, Ischemia, QT
Data Interpretation and Analysis
Global Study Management
Regulatory Strategy Consultation
Founded in 1983 by Dr. Mitchell Krucoff, the Duke ECG core laboratory has grown in to one of the largest, most experienced academic ECG core laboratories in the world. COResearch not only expands the core laboratory's operational capabilities, but extends its global digital functionality beyond static and continuous ECG measurements to imaging modalities such as echocardiography.
We invite you to visit our website or to call Scott Neff to learn more about this unique organization.
Mr. Scott Neff, Global Business Development
2424 Erwin Road, Suite 401
Durham, NC 27705 USA
Last Updated: 06-17-05